Physician profile
Prabha Ranganathan
NPI 1003832304
$6,200.03
in general payments reported to CMS, 2019-2025
10 companies · $1,359 in 2025
The $1,359 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,894 · 2021: $11.60 · 2022: $16.85 · 2023: $1,797 · 2024: $121 · 2025: $1,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Travel and Lodging: $925 · Food and Beverage: $756 · Education: $95.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $925.30 |
| Food and Beverage | $756.45 |
| Education | $95.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,777.20 | 2019 | |
| Amgen INC. | $1,585.67 | 2023-2025 | Tavneos, Enbrel |
| Astrazeneca Uk Limited | $1,213.30 | 2025 | Saphnelo |
| Pfizer INC. | $133.78 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $107.49 | 2023 | Saphnelo |
| Glaxosmithkline, LLC. | $100.07 | 2023 | Benlysta |
| Janssen Biotech, INC. | $99.00 | 2019 | |
| Abbvie INC. | $95.07 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $59.20 | 2024 | Orencia |
| Ucb, INC. | $29.25 | 2023 | Cimzia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabha Ranganathan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.